Download Files:
CZC-8004
SKU
HY-111138-1 mg
Category Reference compound
Tags Cancer, EGFR;VEGFR, JAK/STAT Signaling;Protein Tyrosine Kinase/RTK
$52 – $380
Products Details
Product Description
– CZC-8004 (CZC-00008004), an aminopyrimidine, is a pan-kinase inhibitor. CZC-8004 can bind a range of tyrosine kinases, including EGFR and VEGFR2 with IC50 values of 650 and 437 nM, respectively[1].
Web ID
– HY-111138
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C17H16FN5
References
– [1]Ying ZD, et, al. Integrated in silico-in vitro analysis of systematic kinase gatekeeper mutation effects on pan-kinase inhibitors in targeted liver cancer therapy. J Chin Chem Soc. 2020 Oct 29;1-10.|[2]Deane FM, et, al. FD5180, a Novel Protein Kinase Affinity Probe, and the Effect of Bead Loading on Protein Kinase Identification. ACS Omega. 2017 Jul 31;2(7):3828-3838.|[3]Hubbard RD, et, al. Advances towards the development of ATP-competitive small-molecule inhibitors of the insulin-like growth factor receptor (IGF-IR). ChemMedChem. 2007 Jan;2(1):41-6.
CAS Number
– 916603-07-1
Molecular Weight
– 309.34
Compound Purity
– 99.61
SMILES
– FC1=CN=C(NC2=CC=C(CN)C=C2)N=C1NC3=CC=CC=C3
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 77.5 mg/mL (ultrasonic)
Target
– EGFR;VEGFR
Pathway
– JAK/STAT Signaling;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.